• Türkçe
    • English
  • English 
    • Türkçe
    • English
  • Login
View Item 
  •   DSpace@MEF
  • Fakülteler
  • İktisadi İdari ve Sosyal Bilimler Fakültesi
  • Ekonomi | Economics
  • İİSBF, EB, Makale Koleksiyonu
  • View Item
  •   DSpace@MEF
  • Fakülteler
  • İktisadi İdari ve Sosyal Bilimler Fakültesi
  • Ekonomi | Economics
  • İİSBF, EB, Makale Koleksiyonu
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.
Advanced Search

Clinical and economic burden associated with cardiovascular events among patients with hyperlipidemia: a retrospective cohort study

Thumbnail

View/Open

Yayıncı Sürümü - Makale (1.062Mb)

Access

info:eu-repo/semantics/openAccess

Date

2016

Author

Fox, Kathleen M
Wang, Li
Gandra, Shravanthi R
Quek, Ruben G. W
Li, Lu
Başer, Onur

Metadata

Show full item record

Citation

Fox, Kathleen M., Wang, Li, Gandra, Shravanthi R., Quek, Ruben G. W., Li, Lu, & Baser, Onur. (2016). Clinical and economic burden associated with cardiovascular events among patients with hyperlipidemia: a retrospective cohort study. BioMed Central.

Abstract

Background: Annual direct costs for cardiovascular (CV) diseases in the United States are approximately $195.6 billion, with many high-risk patients remaining at risk for major cardiovascular events (CVE). This study evaluated the direct clinical and economic burden associated with new CVE up to 3 years post-event among patients with hyperlipidemia. Methods: Hyperlipidemic patients with a primary inpatient claim for new CVE (myocardial infarction, unstable angina, ischemic stroke, transient ischemic attack, coronary artery bypass graft, percutaneous coronary intervention and heart failure) were identified using IMS LifeLink PharMetrics Plus data from January 1, 2006 through June 30, 2012. Patients were stratified by CV risk into history of CVE, modified coronary heart disease risk equivalent, moderate-and low-risk cohorts. Of the eligible patients, propensity score matched 243,640 patients with or without new CVE were included to compare healthcare resource utilization and direct costs ranging from the acute (1-month) phase through 3 years post-CVE date (follow-up period). Results: Myocardial infarction was the most common CVE in all the risk cohorts. During the acute phase, among patients with new CVE, the average incremental inpatient length of stay and incremental costs ranged from 4.4-6.2 days and $25,666-$30,321, respectively. Acute-phase incremental costs accounted for 61-75 % of first-year costs, but incremental costs also remained high during years 2 and 3 post-CVE. Conclusions: Among hyperlipidemic patients with new CVE, healthcare utilization and costs incurred were significantly higher than for those without CVE during the acute phase, and remained higher up to 3 years post-event, across all risk cohorts.

Source

Bmc Cardiovascular Disorders

Volume

16

URI

http://dx.doi.org/10.1186/s12872-016-0190-x
https://hdl.handle.net/20.500.11779/649

Collections

  • Araştırma Çıktıları, PubMed Koleksiyonu [72]
  • Araştırma Çıktıları, Scopus İndeksli Yayınlar Koleksiyonu [455]
  • Araştırma Çıktıları, WOS İndeksli Yayınlar Koleksiyonu [482]
  • İİSBF, EB, Makale Koleksiyonu [61]



DSpace software copyright © 2002-2015  DuraSpace
Contact Us | Send Feedback
Theme by 
@mire NV
 

 




| Instruction | Guide | Contact |

DSpace@MEF

by OpenAIRE

sherpa/romeo

Browse

All of DSpaceCommunities & CollectionsBy Issue DateAuthorsInstitution AuthorTitlesORCIDSubjectsTypeLanguageDepartmentCategoryPublisherAccess TypeThis CollectionBy Issue DateAuthorsInstitution AuthorTitlesORCIDSubjectsTypeLanguageDepartmentCategoryPublisherAccess Type

My Account

LoginRegister

Statistics

View Google Analytics Statistics

DSpace software copyright © 2002-2015  DuraSpace
Contact Us | Send Feedback
Theme by 
@mire NV
 

 


|| Guide|| Instruction || Library || MEF University || OAI-PMH ||

MEF University Library, İstanbul, Turkey
If you find any errors in content please report us

Creative Commons License
MEF University Institutional Repository is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 Unported License..

DSpace@MEF:


DSpace 6.2

tarafından İdeal DSpace hizmetleri çerçevesinde özelleştirilerek kurulmuştur.